Peter Maimonis

Mucins bearing the cancer-associated sialosyl-Tn antigen mediate inhibition of natural killer cell cytotoxicity.

Shunji Ogata, Peter Maimonis, Steven H. Itzkowitz · PubMed · 1992 · 121 citations

Cancer Immunosurveillance, Medicine, Immunology +11

Tumor selective reactivity of a monoclonal antibody prepared against a recombinant peptide derived from the DF3 human breast carcinoma-associated antigen.

Lucien Perey, Daniel F. Hayes, Peter Maimonis et al. · PubMed · 1992 · 104 citations

Immunology, Pathology, Antigen Processing +24

Comparison of Methods of Measuring HER-2 in Metastatic Breast Cancer Patients Treated With High-Dose Chemotherapy

Lyndsay N. Harris, Vlayka Liotcheva, Gloria Broadwater et al. · Journal of Clinical Oncology · 2001 · 97 citations

Elevated soluble MUC1 levels and decreased anti-MUC1 antibody levels in patients with multiple myeloma

Steven P. Treon, Peter Maimonis, Deborah Bua et al. · Blood · 2000 · 83 citations

Influence of circulating c-erbB-2 serum protein on response to adjuvant chemotherapy in node-positive breast cancer patients

Tanja Fehm, Peter Maimonis, Stephen Weitz et al. · Breast Cancer Research and Treatment · 1997 · 69 citations

C-erbb-2 Serum Protein, Breast Oncology, Medicine +9